Search Results

滋肾活血方治疗原发性肝癌患者分子靶向药物相关蛋白尿的有效性评价.

• Authors : 景, 婧¹ (AUTHOR); 张, 傲哲¹ (AUTHOR); 余, 思邈¹ (AUTHOR)

• Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Apr2026, Vol. 42 Issue 4, p874-881. 8p.

Record details

Molecular Targeted Therapy for Chronic Non-Bacterial Mastitis: New Insights into Pathophysiology and Therapeutic Strategies

• Authors : Xuan Z; Zheng K; Zhang D

Subjects: Chronic Non-bacterial Mastitis; Plasma Cell Mastitis; Idiopathic Granulomatous Mastitis

• Source: International Journal of Women's Health, Vol 18, Iss Issue 1, Pp 1-13 (2026)

Record details

Molecular-targeted therapy in ameloblastoma: a systematic review

• Authors : Lilies Dwi Sulistyani; Vera Julia; Dwi Ariawan

Subjects: Review Article

• Source: Arch Craniofac Surg

Record details

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study

• Authors : Liu J; Wang Y; Cui L

Subjects: Molecular Targeted Therapy; PD-(L)1; Hepatocellular Carcinoma

• Source: ImmunoTargets and Therapy, Vol 14, Iss Issue 1, Pp 761-771 (2025)

Record details

Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm

• Authors : Arthur, C, Author; Carlson, L-M, Author; Svoboda, J, Author ...

• Source: NPJ PRECISION ONCOLOGY. 8(1)

Record details

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database

• Authors : Tomoyuki Koguchi; Sei Naito; Shingo Hatakeyama

Subjects: immune checkpoint inhibitor; immune‐oncology; Neoplasms. Tumors. Oncology. Including cancer and carcinogens

• Source: Cancer MedCancer Medicine, Vol 12, Iss 22, Pp 20677-20689 (2023)

Record details

Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy.

• Authors : Tanaka T; Laboratory of Veterinary Surgery, School of Veterinary Science, Osaka Metropolitan University, Osaka, Japan.; Motegi T

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/veterinary

• Source: BMC research notes [BMC Res Notes] 2024 Dec 02; Vol. 17 (1), pp. 357. Date of Electronic Publication: 2024 Dec 02.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500

Record details

Molecular targeted therapy, advanced treatment for cancers of the head-and-neck region: A systematic review

• Authors : Firdous, Shaikh; Sonia Kaur, Sodhi; Lata M, Kale

Subjects: Neoplasms; Humans; Antineoplastic Agents

• Source: Journal of Cancer Research and Therapeutics. 19:1206-1211

Record details

Research progress in molecular targeted therapy for inflammatory bowel disease

• Authors : Nan Liu; Chengye Pan; Lishuai Qu

Subjects: Medicine

• Source: Journal of Translational Medicine, Vol 24, Iss 1, Pp 1-16 (2025)

Record details

Dementia incidence varied by anticancer drugs and molecular targeted therapy in a population-based cohort study.

• Authors : Lee EH; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.; Kang D

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Dementia*/Dementia*/Dementia*/epidemiology ; Dementia*/Dementia*/Dementia*/drug therapy

• Source: Scientific reports [Sci Rep] 2024 Jul 30; Vol. 14 (1), pp. 17485. Date of Electronic Publication: 2024 Jul 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details